GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 1801 - 1850 of 39437 in total
PDB ID UniProt ID Title Descriptor ▲
6DID Q2N0S6 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID Q2N0S7 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID 6DID HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID P01840 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID 6DID HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID P01840 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID A0A1Y1B8B1 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID A0A1Y1B8B1 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6EDU B3UEZ6 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU B3UES2 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU P01730 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU 6EDU B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6CM3 Q2N0S7 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 Q2N0S5 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 P01730 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 6CM3 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6MEO P01730 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MEO P51681 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MEO Q70145 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MET P01730 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MET P51681 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MET Q70145 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
5VN8 B3UEZ6 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN8 B3UES2 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN8 5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
6DFH Q2N0S6 BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFH Q2N0S5 BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFH 6DFH BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFG Q2N0S6 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFG Q2N0S8 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFG 6DFG BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6NNJ Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6NNJ 6NNJ Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6NM6 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6NM6 6NM6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6XRT Q2N0S6 Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain
6XRT 6XRT Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain
6ORN 6ORN Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain
6OKP B3UEZ6 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP B3UES2 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP S6B291 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP S6B291 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP Q8N5F4 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP Q8N5F4 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP P01834 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP P01834 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6ORQ 6ORQ Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab275MUR antibody Fab heavy chain, Ab275MUR antibody Fab light chain
6ORP 6ORP Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab897NHP antibody Fab heavy chain, Ab897NHP antibody Fab light chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024